These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 304258)

  • 21. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
    Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
    Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microheterogeneity of human antithrombin III.
    Borsodi A; Narasimhan TR
    Br J Haematol; 1978 May; 39(1):121-7. PubMed ID: 666974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V; Béguin S; Boneu B; Hemker HC
    Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proceedings: The relationship between antithrombin III, progressive antithrombin activity and anti Xa activity in plasma.
    Whigham K; Howie PW; Forbes CD; Prentice CR
    Thromb Diath Haemorrh; 1975 Sep; 34(1):365. PubMed ID: 52904
    [No Abstract]   [Full Text] [Related]  

  • 25. Antithrombin, antitrypsin and antichymotrypsin activities of the salivary gland secretion and intestinal chyme of medicinal leeches. Antichymotrypsin activity of partially purified preparations of hirudin and pseudohirudin.
    Baskova IP; Nikonov GI; Cherkesova OU
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):831-7. PubMed ID: 6083960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antithrombin III deficiency and tendency to thrombosis (author's transl)].
    Lechner K; Thaler E; Niessner H; Nowotny C; Partsch H
    Wien Klin Wochenschr; 1977 Apr; 89(7):215-22. PubMed ID: 857429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Standardization of the laboratory method for antithrombin activity measurement].
    Okajima K
    Rinsho Byori; 2002 Mar; 50(3):283-6. PubMed ID: 11985057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
    Derkx FH; Bouma BN; Schalekamp MA
    J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome].
    Campo G; Modena N; Gallo A; Ciaffoni S
    Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An unusual type of alpha1-antitrypsin deficiency in a child.
    Langley CE; Berninger RW; Wolfson SL; Talamo RC
    Johns Hopkins Med J; 1979 May; 144(5):161-5. PubMed ID: 312969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
    Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K
    Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Material isolated from normal and variant human liver that immunologically crossreacts with alpha1-antitrypsin.
    Matsubara S; Yoshida A; Lieberman J
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3334-7. PubMed ID: 4139709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new assay for the measurement of total progressive antithrombin.
    Lane JL; Bird P; Rizza CR
    Br J Haematol; 1975 May; 30(1):103-15. PubMed ID: 53064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification of canine antithrombin III-heparin cofactor using affinity chromatography.
    Damus PS; Wallace GA
    Biochem Biophys Res Commun; 1974 Dec; 61(4):1147-53. PubMed ID: 4141897
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical multicenter evaluation of a new FXa-based Antithrombin assay.
    Merz M; Böhm-Weigert M; Braun S; Cooper PC; Fischer R; Hickey K; Steffan A; Kemkes-Matthes B; Kitchen S
    Int J Lab Hematol; 2011 Oct; 33(5):498-506. PubMed ID: 21535419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and characterisation of magnetised Dacron-heparin composite employed for antithrombin affinity purification.
    Mercês AA; Silva RS; Silva KJ; Maciel JD; Oliveira GB; Buitrago DM; de Aguiar JA; de Carvalho-Júnior LB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1038():73-79. PubMed ID: 27810279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rabbit as an animal model for the activated factor X-antithrombin III-heparin reaction.
    Gitel SN; Wessler S; Medina VM
    Circ Res; 1977 Aug; 41(2):187-91. PubMed ID: 872292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of experimental inflammation on the synthesis and distribution of antithrombin III and alpha1-antitrypsin in rabbits.
    Koj A; Regoeczi E
    Br J Exp Pathol; 1978 Oct; 59(5):473-81. PubMed ID: 309765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of antithrombin III and alpha-1-antitrypsin by the perfused rat liver.
    Koj A; Regoeczi E; Toews CJ; Leveille R; Gauldie J
    Biochim Biophys Acta; 1978 Apr; 539(4):496-504. PubMed ID: 305791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical comparison of four commercially available human α
    Boerema DJ; An B; Gandhi RP; Papineau R; Regnier E; Wilder A; Molitor A; Tang AP; Kee SM
    Biologicals; 2017 Nov; 50():63-72. PubMed ID: 28882403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.